Sherif Sayed

1. Collaborate with the brand team to identify opportunities related to achieving optimal pricing within each market and be a crucial contributor to delivering brand objectives.
2. Create and implement price related standard operating procedures (SOP), seek necessary endorsement and approval and communicate to each country within the NEMEA Area.
3. Train all internal stakeholders on pricing related SOPs
4. Ensure SOPs will achieve optimal pricing based on market demographics and regional and global pricing strategies.
5. Price risk analysis to be conducted on a regular basis on existing and new products based on regional and international price referencing.
6. Collaborate and partner with regional and cluster business operation and support functions on assessing price request to ensure prices are aligned with regional and global pricing strategies to achieve optimal prices and reimbursement within each market.
7. Assessing price requests business cases within the region
8. Collaborate and assist the cluster in their price argumentations, if needed, by communicating value preposition during price submissions or helping them during appealing on price changes.
9. Consolidate all Government price regulations for countries
10. Secure the Takeda Pricing System is updated with consolidated published prices consistent with the prices granted by health authorities upon registration in each market.
11. Liaise with the regulatory function and follow up price certificate processing by providing international price referencing lists and liaising with global pricing for the processing the price certificates for legalization.
12. Communicate value preposition to key governmental stakeholders to achieve optimum prices or protect prices
13. Support and collaborate with the cluster on tendering and discount activities for key private and government accounts within the region
14. Conduct financial impact studies on any price change activities (decrease/increase) in view of overall pricing history and future IRP evolution within each market

1. Manage a team of direct reporters ( commercial manager - 2 Key account managers - field force trainer - business analyst and field force effectiveness manager)
2. Conduct market access prelaunch activities:
- Payer/ key decision maker / regional center mapping
- Evidence generation & publication plan
- Value dossier generation
- Pricing strategy & approval
- Evaluate, design, approve, and execute Patient Access Program (PAP) where applicable
- Conduct payer meetings - educational/ad board/hospital-based
- Secure reimbursement, funding, formulary listings
3. Develop and execute market access strategies to influence and accelerate favourable pricing and reimbursement decisions for key market brands and new launches
4. Participate actively in all steps of pricing & reimbursement planning, execution and negotiation, incorporating health economic tools into the local pricing negotiation process, to ensure listing
5. Build new programs or implement existing global access models tailor made to local country needs through a deeper understanding of patient needs and science of products and be responsible with cross functional teams for commercial and corporate impact.
6. Champion innovative pricing/commercial models through stakeholders engagements with an emphasis of practical and early implementation of marketing value proposition.
7. Ensure best launch and in-market prices according to the market situation, aligned with BU decisions, and regional and/or global strategies.
8. Identify access gap for near to launch, current and near patent expiry products as part of life cycle management (reimbursement and/or payer limitation, government budget allocation, major health care institution priorities).
9. Deploy reference price decisions in consultation with regional and global pricing teams.
10. Interact in external debates around access, pricing and reimbursement issues with the aim of achieving better market access of a given therapy.
11. Participate in local market access committees and activities towards prioritization, alignment, sharing experiences and best practices.
12. Support inter disciplinary negotiations on treatment guidelines with key authorities in order to maintain reimbursement levels for the adequate use of the therapy with a focus on patients access and outcomes.